Privia Health Group Inc (NASDAQ: PRVA) open the trading on Wednesday, with great promise as it jumped 1.70% to $19.78, before settling in for the price of $19.45 at the close. Taking a more long-term approach, PRVA posted a 52-week range of $16.47-$26.09.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The company of the Healthcare sector’s yearbook sales growth during the past 5- year span was recorded 7.98%. Meanwhile, its Annual Earning per share during the time was 7.98%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 87.42%. This publicly-traded company’s shares outstanding now amounts to $121.39 million, simultaneously with a float of $107.95 million. The organization now has a market capitalization sitting at $2.41 billion. At the time of writing, stock’s 50-day Moving Average stood at $21.46, while the 200-day Moving Average is $22.09.
Privia Health Group Inc (PRVA) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Health Information Services industry. Privia Health Group Inc’s current insider ownership accounts for 11.46%, in contrast to 94.30% institutional ownership. According to the most recent insider trade that took place on May 13 ’25, this organization’s Chief Executive Officer sold 15,909 shares at the rate of 24.52, making the entire transaction reach 390,089 in total value, affecting insider ownership by 407,234. Preceding that transaction, on May 12 ’25, Company’s Chief Executive Officer sold 13,773 for 24.99, making the whole transaction’s value amount to 344,187. This particular insider is now the holder of 423,143 in total.
Privia Health Group Inc (PRVA) Earnings and Revenue Records
Wall Street market experts anticipate that the next fiscal year will bring earnings of 0.21 per share during the current fiscal year.
Privia Health Group Inc’s EPS increase for this current 12-month fiscal period is 87.42% and is forecasted to reach 0.33 in the upcoming year. Considering the longer run, market analysts have predicted that Company’s EPS will increase by 61.41% through the next 5 years, which can be compared against the 7.98% growth it accomplished over the previous five years trading on the market.
Privia Health Group Inc (NASDAQ: PRVA) Trading Performance Indicators
Let’s observe the current performance indicators for Privia Health Group Inc (PRVA). It’s Quick Ratio in the last reported quarter now stands at 1.88. Alongside those numbers, its PE Ratio stands at $160.03, and its Beta score is 0.80. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 1.34. Similarly, its price to free cash flow for trailing twelve months is now 20.38.
In the same vein, PRVA’s Diluted EPS (Earnings per Share) trailing twelve months is recorded 0.12, a figure that is expected to reach 0.05 in the next quarter, and analysts are predicting that it will be 0.33 at the market close of one year from today.
Technical Analysis of Privia Health Group Inc (PRVA)
[Privia Health Group Inc, PRVA] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 53.12% While, its Average True Range was 46.85%.
Raw Stochastic average of Privia Health Group Inc (PRVA) in the period of the previous 100 days is set at 13.80%, which indicates a major fall in contrast to 43.35% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 0.65 that was lower than 0.75 volatility it exhibited in the past 100-days period.
